Eddouks, M., Khallouki, F., Owen, R., Hebi, M., & Burcelin, R. (2019). Evaluation of glucose and lipid lowering activity of arganimide a in normal and streptozotocin-induced diabetic rats. Endocrine, metabolic & immune disorders, drug targets, 19(4), . https://doi.org/10.2174/1871530318666181113124727
Chicago-Zitierstil (17. Ausg.)Eddouks, Mohamed, Farid Khallouki, Robert Owen, Morad Hebi, und Remy Burcelin. "Evaluation of Glucose and Lipid Lowering Activity of Arganimide a in Normal and Streptozotocin-induced Diabetic Rats." Endocrine, Metabolic & Immune Disorders, Drug Targets 19, no. 4 (2019). https://doi.org/10.2174/1871530318666181113124727.
MLA-Zitierstil (9. Ausg.)Eddouks, Mohamed, et al. "Evaluation of Glucose and Lipid Lowering Activity of Arganimide a in Normal and Streptozotocin-induced Diabetic Rats." Endocrine, Metabolic & Immune Disorders, Drug Targets, vol. 19, no. 4, 2019, https://doi.org/10.2174/1871530318666181113124727.